Homogreft, Otogreft ve Heterogreftler

Persson, M., Glaser, N., Nilsson, J., Friberg, Ö., Franco-Cereceda, A., & Sartipy, U. (2022). Comparison of Long-term Performance of Bioprosthetic Aortic Valves in Sweden From 2003 to 2018. JAMA Network Open, 5(3), e220962. https://doi.org/10.1001/jamanetworkopen.2022.0962

Ozdogan ME, Halit V, Oktar L et al. Homograft Valve Replacement in the Aortic Position. Jpn Ann Thorac Surg, 1993;13:45-8.

Lucas Van Hoof L.V. at all. ‘’Long-term outcome after the Ross procedure in 173 adults with up to 25 years of follow-up’’. European Journal of Cardio-Thoracic Surgery, Volume 66, Issue 1, July 2024, ezae267, https://doi.org/10.1093/ejcts/ezae267

O’Brien MF. Homografts and autografts. In: Baue AE, Geha AS, Hammond GL, Laks H, Naunheim KS, ed. Glenn’s Thoracic and Cardiovascular Surgery. Vol 2. 6th ed. Stamford (CT): Appleton & Lange, 1996;2005-42.

Ebken J. at all. ‘’Residual immune response towards decellularized homografts may be highly individual’’. European Journal of Cardio-Thoracic Surgery, Volume 59, Issue 4, April 2021, Pages 773–782, https://doi.org/10.1093/ejcts/ezaa393

Staab ME, Nishimura RA, Dearani JA, Orszulak TA. Aortic valve homografts in adults: A clinical perspecti- ve. Mayo Clin Proc, 1998;73:231-8.

Lam CR, Aram HH, Munnell ER. An experimental study of aortic valve homografts. Surg Gynecol Obstet, 1952;94:129.

Murray G. Homologous aortic-valve-segment transp- lants as surgical treatment for aortic and mitral insuffi- ciency. Angiology, 1956;7:466.

Beall AC, Morris GC, Cooley DA et al. Homo-transplan- tationof the aortic valve. J Thorac Cardiovasc Surg, 1961;42:497.

Duran CG, Gunning AJ. A method for placing a total homologous aortic valve in the subcoronary position. Lancet, 1962;2:488.

Peterss S at all. ‘’Aortic valved homograft degeneration: surgical or transcatheter approach for repeat aortic valve replacement?’’European Journal of Cardio-Thoracic Surgery, Volume 66, Issue 1, July 2024, ezae280, https://doi.org/10.1093/ejcts/ezae280

Ross DN. Homograft replacement of the aortic valve. Lancet, 1962;2:487.

Barratt-Boyes BG. Homograft aortic valve replacement in aortic incompetence and stenosis. Circulation, 1964;19:131.

Huyan, Y., & Song, J. (2021). Application of Homograft Valved Conduit in Cardiac Surgery. Frontiers in Cardiovascular Medicine, 8, Article 740871. https://doi.org/10.3389/fcvm.2021.740871

Yacoub M, Rasmi NR, Sundt TM et al. Fourteen-year experience with homovital homografts for aortic valve replacement. J Thorac Cardiovasc Surg, 1995;110:186-93.

Rajab, T. K., Ochoa, B., Zilinskas, K., Kwon, J., Taylor, C. L., Henderson, H. T., Savage, A. J., Kavarana, M., Turek, J. W., & Costello, J. M. (2023). Partial heart transplantation for pediatric heart valve dysfunction: A clinical trial protocol. PLOS ONE, Published February 7, 2023. https://doi.org/10.1371/journal.pone.0280163

Rahimtoola SH. The problem of valve prosthesis-pati- ent mismatch. Circulation, 1978;58:20-4.

Jaffe WM, Coverdale HA, Roche AH et al. Rest and exercise hemodynamics of 20 to 23mm allograft, Medtronic Intact (porcine), and St. Jude Medical valves in the aortic position. J Thorac Cardiovasc Surg, 1990;100:167-74.

Cannegieter SC, Rosendaal FR, Wintzen AR et al. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med, 1995;333:11-7.

Matsuki O, Rubles A, Gibbs S, Bodnar E, Ross DN. Long-term performance of 555 aortic homograft in the aortic position. Ann Thorac Surg, 1988;46:187-91.

Özdoğan ME, Oktar L, Günaydın S et al. Homograft valve replacement for native and prosthetic aortic valve endocarditis. Gazi Medical Journal, 1996;7:79-83.

Gott VL, Cameron DE, Reitz BA, Pyeritz RE. Current diagnosis and prescription for the Marfan syndrome: Aortic root and valve replacement. J Card Surg, 1994;9:177-81.

Gott VL, Gillinov AM, Pyeritz RE et al. Aortic root replacement: Risk factor analysis of a seventeen-year expe- rience with 270 patients. J Thorac Cardio-vasc Surg, 1995;109:536-44.

Prager RL, Deschner W, Kong B et al. Early experience with homograft aortic root replacement for complex aortic pathology. Surgery, 1993;114:794-8.

Glazier JJ, Verwilghen J, Donaldson RM, Ross DN. Treatment of complicated prosthetic aortic valve endo- carditis with annular abscess formation by homograft aortic root replacement. J Am Coll Cardiol, 1991;17:1177-82.

Kula S, Erer D, Büyükateş M et al. Brucella endocardi- tis: Case report and review of the literature. J Heart Valve Dis, 2001;10:486-8.

O’Brien MF, Harrocks S, Stafford EG et al. The homo- graft aortic valve: A 29-year, 99.3% follow up of 1022 valve replacements. J Heart Valve Dis, 2001;10:334-44.

Kirklin JK, Smith D, Novick W et al. Long-term function of cryopreserved aortic homografts: A ten-year study. J Thorac Cardiovasc Surg, 1993;106:154-65.

Knott-Craig CJ, Elkins RC, Stelzer PL et al. Homograft replacement of the aortic valve and root as a functional unit. Ann Thorac Surg, 1990;49:619-24.

Dearani JA, Orszulak TA, Daly RC et al. Comparison of techniques for implantation of aortic valve allografts. Ann Thorac Surg, 1996;62:1069-75.

O’Brien MF, Stafford EG, Gardner MA et al. Allograft aortic valve replacement: Long-term follow-up. Ann Thorac Surg, 1995;60:65-70.

Dearani JA, Orszulak TA, Schaff HV et al. Results of allograft aortic valve replacement for complex endo- carditis. J Thorac Cardiovasc Surg, 1997;113:285-291.

Vogt PR, von Segesser LK, Jenni R et al. Emergency surgery for acute infective aortic valve endocarditis: Performance of cryopreserved homografts and mode of failure. Eur J Cardithorac Surg, 1997;11:53-61.

Ozdogan ME, Oktar L, Gunaydin S et al. Mitral and aortic valve replacement using fresh unstented pulmonary and aortic homografts. J Heart Valve Dis,1996;5:181-5.

Yacoub M, Towers M, Somerville W. Results of mitral valve replacement using unstented fresh semilunar valve homografts. Circulation, 1972;45(Suppl 1):44-51.

Acar C. Mitral valve homograft for mitral and tricuspid valve replacement. In: Franco KL, Verrier ED, ed. Advanced Therapy in Cardiac Surgery. Hamilton: B.C. Decker, 1999;195-200.

Sievers HH, Lange PE, Yankah AC et al. Allogeneic transplantation of the mitral valve. An open question. Thorac Cardiovasc Surg, 1986;33:227-9.

Pomar JL, Mestres CA. Tricuspid valve replacement using a mitral homograft: Surgical technique and initi- al results. J Heart Valve Dis, 1993;2:125-128.

Acar C, Farge A, Ramsheyi A et al. Mitral valve replace- ment using a mitral homograft. Ann Thorac Surg, 1994;57:746-8.

Kumar AS, Trehan H. Homograft mitral valve replace- ment. A case report. J Heart Valve Dis, 1994;3:473-5.

Peterss, S., Fabry, T. G., Steffen, J., Orban, M., Buech, J., Radner, C., Theiss, H. D., Pichlmaier, M., Massberg, S., & Hagl, C. (2024). Aortic valved homograft degeneration: surgical or transcatheter approach for repeat aortic valve replacement? European Journal of Cardio-Thoracic Surgery, 66(1), ezae280. https://doi.org/10.1093/ejcts/ezae280

Galzerano, D., Kholaif, N., Al Amro, B., Al Admawi, M., Eltayeb, A., Alshammari, A., Di Salvo, G., & Al-Halees, Z. Y. (2024). The Ross Procedure: Imaging, Outcomes and Future Directions in Aortic Valve Replacement. Journal of Clinical Medicine, 13(2), 630. https://doi.org/10.3390/jcm13020630.

Matsuki O, Okita Y, Almeida RS et al. Two decades’ experience with aortic valve replacement with pulmo- nary autograft. J Thorac Cardiovasc Surg, 1988;95:705- 11.

Elkins RC, Knott-Craig CJ, Ward KE, McCue C, Lane MM. Pulmonary autograft in children: Realized growth potential. Ann Thorac Surg, 1994;57:1387-94.

Kouchoukos NT, Davila-Roman VG, Spray TL, Murphy SF, Perrillo JB. Replacement of the aortic root with a pulmonary autograft in children and young adults with aortic valve disease. N Engl J Med, 1994;330:1-6.

Özdoğan ME, Günaydın S, Sinci V et al. İnfektif aort kapak endokarditlerinin cerrahi tedavisinde Ross pro- sedürü: Olgu sunumu. GKD Cer Derg, 1997;5:61-4.

Elkins RC. Pulmonary autograft. In: Franco KL, Verrier ED, ed. Advanced Therapy in Cardiac Surgery. Hamilton: B.C. Decker Inc, 1999;183-94.

Galzerano, D., Kholaif, N., Al Amro, B., Al Admawi, M., Eltayeb, A., Alshammari, A., Di Salvo, G., & Al-Halees, Z. Y. (2024). The Ross Procedure: Imaging, Outcomes and Future Directions in Aortic Valve Replacement. Journal of Clinical Medicine, 13(2), 630. https://doi.org/10.3390/jcm13020630.

Van Suylen RJ, Schoff PH, Bos E et al. Pulmonary auto- graft failure after aortic root replacement in a patient with juvenile rheumatoid arthritis. Eur J Cardiothoracic Surg, 1992;10:571-2.

Kouchoukos NT. Aortic allografts and pulmonary auto- grafts for replacement of the aortic valve and aortic root. Ann Thorac Surg, 1999;67:1846-1848.

Ross D, Jackson M, Davies J. Pulmonary autograft aor- tic valve replacement: Long-term results. J Card Surg, 1991;6:529-33.

Galzerano, D., Kholaif, N., Al Amro, B., Al Admawi, M., Eltayeb, A., Alshammari, A., Di Salvo, G., & Al-Halees, Z. Y. (2024). The Ross Procedure: Imaging, Outcomes and Future Directions in Aortic Valve Replacement. Journal of Clinical Medicine, 13(2), 630. https://doi.org/10.3390/jcm13020630.

Knott-Craig CJ, Elkins RC, Santangelo KL, McCue C, Lane MM. Aortic valve replacement: Comparison of late survival between autografts and homografts. Ann Thorac Surg, 2000;69:1327-32.

Anastasiadis, K., Kambouroglou, D., & Spanos, P. (2004). The Use of Valve Homografts and Autografts in Adult Cardiac Surgery. Hellenic Journal of Cardiology, 45, 36-41. https://doi.org/10.1016/S1109-9666(04)80021-4.

David TE, Omran A, Webb G et al. Geometric mis- match of the aortic and pulmonary roots causes aortic insufficiency after the Ross procedure. J Thorac Cardiovasc Surg, 1996;112:1231-9

David TE, de Sa MPL, Ivanov J et al. Dilation of the pul- monary autograft after the Ross procedure. J Thorac Cardiovasc Surg, 2000;119:210-20.

Elkins RC, Lane MM, McCue C. Pulmonary autograft reoperation: Incidence and management. Ann Thorac Surg, 1996;62:450-5.

Kaneko, T., & Ouzounian, M. (2024). The Longest Reported Outcomes of the Ross Procedure. JAMA Cardiology, 9(1), 14-15. https://doi.org/10.1001/jamacardio.2023.4100.

Elkins RC. The Ross operation: A 12 year experience. Ann Thorac Surg, 1999;68:14-8.

Elkins RC, Knott-Craig CJ, Howell CE. Pulmonary auto- grafts in patients with aortic annulus dysplasia. Ann Thorac Surg, 1996;61:1141-5.

Kabbani SS, Jamil H, Hammoud A et al. Use of the pul- monary autograft for mitral replacement: Short and medium-term experience. Eur J Cardiothorac Surg, 2001;20:257-61.

Jamieson WRE. Update on mechanical and tissue val- ves. In: Franco KL, Verrier ED, ed. Advanced Therapy in Cardiac Surgery. Hamilton: D.C. Decker Inc, 1999;201- 12.

Yoganatham AP, Chaux A, Gray R et al. Bileaflet tilting disc and porcine aortic valves substitutes: In vitro hydrodynamic characteristics. J Am Coll Cardiol, 1984;3:313.

Jamieson WRE, Gerein AN, Ricci DR et al. Carpentier- Edwards supraannular porcine bioprosthesis: A new generation tissue (clinical and hemodynamic assess- ment). In: Bodnar E, Yacoub M, ed. Biologic and Bioprosthetic Valve: Proceedings of the Third International Symposium. New York: Yorke Medical Books, 1986:141.

Black MM, Cochrame T, Lawford PV et al. Design and flow characteristics. In: Bodnar E, Frater R, ed. Replacement cardiac valves. New York: McGraw-Hill, 1992:1.

Duran CG. The pericardial heart valve: An open questi- on. In: Bodnar E, Frater R, ed. Replacement cardiac val- ves. New York: McGraw-Hill, 1992:277.

Cohn LH, Lipson W. Selection and complications of cardiac valvular prostheses. In: Baue AE, Geha AS, Hammond GL, Laks H, Naunheim KS, ed. Glenn’s Thoracic and Cardiovascular Surgery. Vol 2. 6th ed. Stamford (CT): Appleton & Lange, 1996:2043-55.

Capodanno, D., Petronio, A. S., Prendergast, B., et al. (2017). Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: A consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal, 38, 3382-3390. https://doi.org/10.1093/eurheartj/ehx303.

Burdon TA, Miller DC, Oyer PE et al. Durability of porci- ne valves at fifteen years in a representative North American patient population. J Thorac Cardiovasc Surg, 1992;103:238-52.

Fann JI, Miller DC, Moore KA et al. Twenty-year clinical experience with porcine bioprostheses. Ann Thorac Surg, 1996;62:1301-12.

Jamieson WRE, Munro AI, Miyagishima RT et al. Carpentier-Edwards standard porcine bioprostheses: Clinical performance to seventeen years. Ann Thorac Surg, 1995;60:999-1007.

Brandt, R. R., & Pibarot, P. (2021). Prosthetic heart valves: Part 2 - Antithrombotic management. European Society of Cardiology, 20 (2), 02 June 2021. https://doi.org/10.1093/eurheartj/ehx303.

Peterseim DS, Chen YY, Cheruvu S et al. Long-term out- come after biologic versus mechanical aortic valve rep- lacement in 841 patients. J Thorac Cardiovasc Surg, 1999;117:890-7.

Bortolotti U, Milano A, Mazzaro E et al. Hancock II por- cine bioprosthesis: Excellent durability at intermediate- term follow-up. J Am Coll Cardiol, 1994;24:676.

Kawachi Y, Tanaka J, Tominaga R et al. More than ten years’ follow-up of the Hancock porcine bioprosthesis in Japan. J Thorac Cardiovasc Surg, 1992;104:5.

Aupant M, Neville X, Dreyfus Y et al. The Carpentier- Edwards pericardial aortic valve: Intermediate results in 420 patients. Eur J Cardiothorac Surg, 1994;8:277.

Akar AR, Szafranek A, Alexiou C et al. Use of stentless xenografts in the aortic position: Determinants of early and late outcome. Ann Thorac Surg, 2002;74:1450-8.

Del Rizzo DF, Goldman BS, Christakis GT, David TE. Hemodynamic benefits of the Toronto Stent-less Valve. J Thorac Cardiovasc Surg, 1996;112:1431-45.

Eriksson MJ, Rosfors S, Radegran K, Brodin LA. Effects of exercise on Doppler-derived presure differen- ce, valve resistance, and effective orifice area in diffe- rent aortic valve prostheses of similar size. Am J Cardiol, 1999;83:619-22.

Binet JP, Duran CG, Carpentier A et al. Heterologous aortic valve transplantation. Lancet, 1965;2:1275.

O’Brien MF, Clarebrough JK. Heterograft aortic valve transplantation for human valve disease. Med J Aust, 1966;2:228-30.

Carpentier A, Lemaigne G, Robert K et al. Biolo-gical factors affecting long-term results of valvular hetero- grafts. J Thorac Cardiovasc Surg, 1969;58:467-83.

Cartier PC, Dumesnil JG, Metras J et al. Clinical and hemodynamic performance of the Freestyle aortic root bioprosthesis. Ann Thorac Surg, 1999;67:345-51.

Fries R, Wendler O, Schieffer H et al. Comparati-ve rest and exercise hemodynamics of 23mm stentless versus 23mm stented aortic bioprostheses. Ann Thorac Surg, 2000;69:817-22.

Al-Attar, N. (2011). Next Generation Surgical Aortic Biological Prostheses: "Sutureless Valves". E-Journal of the ESC Council for Cardiology Practice, 10(14), 21 Dec 2011. European Society of Cardiology.

Carrel, T. (2016). Indications and pitfalls of sutureless aortic valves: recommendations are welcome. European Journal of Cardio-Thoracic Surgery, 49(3), 719–720. https://doi.org/10.1093/ejcts/ezv430.

Williams, M. L. at All. (2020). Long-term outcomes of sutureless and rapid-deployment aortic valve replacement: a systematic review and meta-analysis. Annals of Cardiothoracic Surgery, 9(4), 265-279. https://doi.org/10.21037/acs-2020-surd-25.

Jin XY, Pepper JR. Do stentless valves make a differen- ce? Eur J Cardiothorac Surg, 2002;22:95-100.

Walther T, Falk V, Langebartels G, Kruger M. Prospec- tively randomized evaluation of stentless versus con- ventional biological aortic valves: Impact on early reg- ression of left ventricular hy-pertrophy. Circulation, 1999;100(Suppl II):II-6-II-10.

Westaby S, Jin XY, Vaccari G, Katsumata T. The Sorin stentless pericardial valve: Implant technique and hemodynamic profile. Semin Thorac Cardiovasc Surg, 1999;11(4 (Suppl 1):62-8.

Gelsomino S, Frassani R, Porreca L et al. Early and midterm results of model 300 Cryolife O’Brien sten- tless porcine aortic bioprosthesis. Ann Thorac Surg, 2001;71:297-301.

Westaby S, Horton M, Jin XY et al. Survival advantages of stentless bioprostheses. Ann Thorac Surg, 2000;70:785-91.

Collinson J, Henein M, Flather M et al. Valve replace- ment for aortic stenosis in patients with poor left ven- tricular function. Circulation, 1999;100(Suppl II):1-5.

Jin XY, Zhong MZ, Gibson DG, Yacoub MH, Pepper JR. Effects of valve substitutes on changes in left ventricu- lar function and hypertrophy after aortic valve replace- ment. Ann Thorac Surg, 1996;62:683-90.

David TE, Feindel CM, Scully HE et al. Aortic valve rep- lacement with stentless porcine aortic valves: A ten- year experience. J Heart Valve Dis, 1998;7:250-54.

Mylonas, K. S., & Angouras, D. C. (2023). Bioprosthetic Valves for Lifetime Management of Aortic Stenosis: Pearls and Pitfalls. Journal of Clinical Medicine, 12(22), 7063. https://doi.org/10.3390/jcm12227063

Van Nooten G, Caes F, Franccois K et al. Stentless or stented aortic valve implants in elderly patients. Eur J Cardiothorac Surg, 1999;15:31-6.

Schaefer, A., Dickow, J., Schoen, G., Westhofen, S., Kloss, L., Al-Saydali, T., Reichenspurner, H., Philipp, S. A., & Detter, C. (2018). Stentless vs. stented bioprosthesis for aortic valve replacement: A case matched comparison of long-term follow-up and subgroup analysis of patients with native valve endocarditis. PLOS ONE. https://doi.org/10.1371/journal.pone.0191171.

Luciani GB, Casali G, Auriemma S, Santini F, Mazzucco. Survival after stentless and stented xenograft aortic valve replacement: A con current controlled trial. Ann Thorac Surg, 2002;74:1443-9.